The synergistic predictive value of hemoglobin glycation index and SYNTAX score for coronary artery disease complexity and long-term prognosis after percutaneous coronary intervention

Read full text
Authors: Dongyue Jia, Maoling Jiang, Jie Feng, Junli Pan, Yuqi Tao, Sisi Wang, Si Liu, Hanxiong Liu, Zhen Zhang, Shiqiang Xiong, Lin Cai
Cited by: 1
References: 26

Abstract

Background: The complexity of coronary artery lesions and glucose metabolic disorders contributes to adverse long-term prognosis following percutaneous coronary intervention (PCI). This study aimed to evaluate the synergistic effect of coronary artery lesions-assessed by the SYNTAX score-and glucose metabolic disorders-quantified by the hemoglobin glycation index (HGI)-on predicting major adverse cardiac and cerebrovascular events (MACCEs) after PCI. Methods: A total of 609 coronary artery disease (CAD) patients undergoing PCI were enrolled in the final analysis. HGI was calculated by subtracting the predicted HbA1c (derived from fasting plasma glucose regression) from the observed HbA1c. Pearson's coefficients were used for correlation analyses. Kaplan-Meier and Cox regression analyses were used to assess associations with MACCEs. Mediation analysis evaluated whether the SYNTAX score mediated the HGI-MACCEs relationship. Results: Patients with higher HGI and SYNTAX scores (≥1.16764 and >22, respectively) exhibited a significantly increased mortality risk (p = 0.0052) and more complex coronary lesions. Multivariable analysis confirmed HGI and SYNTAX score as independent predictors of MACCEs. Additionally, the SYNTAX score partially mediated the association between HGI and adverse outcomes, with a mediation proportion of 13.05%. Conclusion: The HGI and SYNTAX score exert a synergistic effect in predicting the severity of CAD and the risk of adverse prognosis after PCI. It highlights the necessity of integrating both metabolic and anatomical assessment indices for comprehensive risk stratification of CAD patients undergoing PCI.

Fields of Study & Subjects

Diabetes Cardiovascular Risks and Lipoproteins Inflammatory Biomarkers in Disease Prognosis Hyperglycemia and glycemic control in critically ill and hospitalized patients

Publication details

Journal / source
Frontiers in Endocrinology
Publisher
Frontiers Media SA
Volume
16
Pages
1727187–1727187
Publication date
13 January 2026
Language
EN